Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
All of these results demonstrated that FSTL3 as a novelty cytokine takes part in the process of atherosclerosis through increasing lipid accumulation and inflammation through regulating CD36 and LOX-1 expression.
|
31815869 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Our findings indicated that myricetin suppressed cholesterol accumulation in macrophage foam cells by inhibition of CD36-mediated ox-LDL uptake, and suggested myricetin may have an important therapeutic function for atherosclerosis.
|
31049071 |
2019 |
Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
The blocking of autophagy-lysosome induction could increase CD36 protein level, foam-cell formation, and migration, thus abolishing the protective effects of CTRP13 on atherosclerosis.
|
30222079 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Both S100A12 and CD36 are implicated in vascular inflammation and atherosclerosis.
|
28756107 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Thus, targeting to CD36 and its downstream effectors may serve as potential new strategies against chronic inflammatory diseases such as atherosclerosis.
|
31625810 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
We found that allergic asthma increased the expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) in the liver and CD36 in the aorta during the acute and advanced stages of atherosclerosis, respectively.
|
31558320 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
These findings indicate that caveolae and CD36 are involved in native LDL endocytosis and suggest that CD36 might be a good candidate for the transport of native LDL across the endothelium, an early event in atherosclerosis.
|
30768959 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
CD36 is associated with regulation of lipid metabolism, atherosclerosis, and blood pressure.
|
31185924 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
In hematopoietic cells, CD36 signaling enhances platelet dysfunction thus decreasing the threshold for platelet activation and accelerating arterial thrombosis, whereas in macrophages, CD36 promotes lipid-laden foam cell formation and atherosclerosis.
|
30825500 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
EP80317 is an hexapeptide that serves as a ligand for CD36 and features protective effects under conditions such as atherosclerosis and vascular inflammation.
|
30886580 |
2019 |
Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
The aim of this study was to investigate the mechanisms through which quercetin protects against atherosclerosis (AS) in apoE‑/‑ mice by regulating the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9), cluster of differentiation 36 (CD36), peroxisome proliferator‑activated receptor γ (PPARγ), liver X receptor α (LXRα) and ATP binding cassette transporter A1 (ABCA1).
|
31524223 |
2019 |
Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Through a TLR4 dependent manner, β2/aβ2 inhibited oxLDL-induced CD36 expression, lipid accumulation and FAK activation, while promoted inflammatory cytokines and MMPs expression in THP-1 macrophages, indicating the novel dual roles played by β2/aβ2 in APS-related atherosclerosis.
|
31654747 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Macrophage foam cell formation mediated by CD36 receptor dependent internalization of oxidized low-density lipoprotein (oxLDL) is an important hallmark of early atherosclerosis.
|
31288519 |
2019 |
Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
In line with these in vitro observations, in the atherosclerosis-susceptible apolipoprotein E (ApoE) KO background, CPT2 M-KO mice demonstrated augmented atherosclerosis, accompanied by increased accumulation of aortic macrophages with elevated CD36 expression.
|
30639412 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Our results inferred that the HSP/GR complex-mediated CD36 axis was involved in the regulation of atherosclerosis development in mice verified by Co-IP assay, EMSA, and Chip-PCR.
|
31632527 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Knockdown of UCA1 greatly inhibited CD36 expression, a crucial biomarker in atherosclerosis.
|
30633352 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
During foam cell formation and atherosclerosis development, the scavenger receptor CD36 plays critical roles in lipid uptake and triggering of atherogenicity via the activation of Vav molecules.
|
31570505 |
2019 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Our results conclude that IL-34 facilitates foam cell formation by increasing CD36-mediated lipid uptake and suggest a potential new risk biomarker for atherosclerosis.
|
30478377 |
2018 |
Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Vim<sup>-/-</sup> mice displayed decreased atherogenesis despite increased vascular inflammation and increased CD36 expression on macrophages in two mouse models of atherosclerosis.
|
30451917 |
2018 |
Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis.
|
29474941 |
2018 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
The present study aimed to explore whether PM<sub>2.5</sub>-exacerbated atherosclerosis was mediated by the cooperation of cluster of differentiation 36 (CD36) and nucleotide-binding oligomerization domain-like receptor protein (NLRP3) inflammasome in apolipoprotein E<sup>-/-</sup> (ApoE<sup>-/-</sup>) mice.
|
29571893 |
2018 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
CD36 has been reported to participate in atherosclerosis process and miR-135a mimics can inhibit its expression while miR-135a inhibitors exhibited a reverse phenomenon.
|
29663503 |
2018 |
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
In conclusion, inhibition of CD36-mediated oxLDL uptake and induction of ABCA1- and ABCG1-dependent cholesterol efflux are two working mechanisms by which andrographolide inhibits macrophage foam cell formation, which suggests that andrographolide could be a potential candidate to prevent atherosclerosis.
|
29298513 |
2018 |
Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
CD36 expression in peripheral blood mononuclear cells reflects the onset of atherosclerosis.
|
28677864 |
2018 |
Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Both persistent up-regulation of CD36 and deficiency of CD36 increase the risk for atherosclerosis.
|
29534172 |
2018 |